Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 686 |
| May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | November 2026 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 21 | 22 | 32 | 24 | 11 | 28 | 0 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 726 |
| Views | |
|---|---|
| United States | 153 |
| Argentina | 103 |
| Canada | 44 |
| Peru | 35 |
| Mexico | 28 |
| Spain | 22 |
| Brazil | 19 |
| Colombia | 15 |
| Ecuador | 13 |
| Chile | 12 |
| Views | |
|---|---|
| Ottawa | 36 |
| Buenos Aires | 28 |
| Lima | 20 |
| Houston | 17 |
| Mexico | 12 |
| Federal | 10 |
| Tokyo | 10 |
| Quito | 9 |
| Hanoi | 8 |
| San Diego | 8 |